BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW)

CUSIP: G11217125

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / *W EXP 12/02/202
Total 13F shares
6,089,638
Share change
+882,532
Total reported value
$838,000
Price per share
$0.14
Number of holders
36
Value change
+$60,913
Number of buys
14
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP G11217125?
CUSIP G11217125 identifies BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) as of Q2 2022

As of 30 Jun 2022, BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,089,638 shares. The largest 10 holders included CLEAR STREET LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Polar Asset Management Partners Inc., GOLDMAN SACHS GROUP INC, Shaolin Capital Management LLC, MMCAP International Inc. SPC, AQR Arbitrage LLC, Cubist Systematic Strategies, LLC, CANTOR FITZGERALD, L. P., and UBS OCONNOR LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.